Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest Income - NetInterest Income - TotalNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Praxis Precision Medicines (PRAX) Profit After Tax: 2019-2024

Historic Profit After Tax for Praxis Precision Medicines (PRAX) over the last 6 years, with Dec 2024 value amounting to -$182.8 million.

  • Praxis Precision Medicines' Profit After Tax fell 42.43% to -$73.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$273.0 million, marking a year-over-year decrease of 80.80%. This contributed to the annual value of -$182.8 million for FY2024, which is 48.30% down from last year.
  • Praxis Precision Medicines' Profit After Tax amounted to -$182.8 million in FY2024, which was down 48.30% from -$123.3 million recorded in FY2023.
  • In the past 5 years, Praxis Precision Medicines' Profit After Tax registered a high of -$61.8 million during FY2020, and its lowest value of -$214.0 million during FY2022.
  • Its 3-year average for Profit After Tax is -$173.4 million, with a median of -$182.8 million in 2024.
  • As far as peak fluctuations go, Praxis Precision Medicines' Profit After Tax tumbled by 170.30% in 2021, and later soared by 42.40% in 2023.
  • Praxis Precision Medicines' Profit After Tax (Yearly) stood at -$61.8 million in 2020, then crashed by 170.30% to -$167.1 million in 2021, then declined by 28.08% to -$214.0 million in 2022, then soared by 42.40% to -$123.3 million in 2023, then crashed by 48.30% to -$182.8 million in 2024.